Congestive Heart Failure

Readmission penalties could harm hospitals and SNFs

Readmission penalties could harm hospitals and SNFs

By

Economic incentives - both good and bad - are a proven way to modify behavior. But what happens when an economic penalty is based on a dubious premise? Many hospitals may soon be forced to answer that question. And many skilled care operators may have to live with some very unwelcome fallout.

Moderate exercise improves depression symptoms in congestive heart failure patients

By

Individuals suffering from both heart failure and depression could see improvement with the introduction of an exercise program, a new study reveals.

Improving care for dual eligibles could lower rehospitalizations, study finds

By

More focused treatment of common illnesses among dually eligible Medicare and Medicaid beneficiaries could cut costs and lower hospital readmissions, researchers found.

Texas long-term care becomes big winner in receipt of federal innovation grants

Texas long-term care becomes big winner in receipt of federal innovation grants

By

Texas has received a windfall of federal funding to test care coordination programs between acute and long-term care providers.

Overnight breathing therapy holds promise for chronic heart failure, research finds

By

An overnight breathing treatment called adaptive servo-ventilation (ASV) therapy was shown to be helpful in individuals with chronic heart failure, new research suggests.

HHS names coordinated care innovation winners

By

The Department of Health and Human Services has announced its newest round of grant recipients under its Health Care Innovation Awards.

Remote monitoring of congestive heart failure and COPD patients may lower readmission rate

A pilot program using remote medical monitoring for recently hospitalized congestive heart failure and chronic obstructive pulmonary disease patients resulted in a lower readmission rate, Crain's Detroit Business reported.

Popular diabetes medication linked to heart attack, death

A new study links the popular diabetes drug Avandia with an increased risk of heart attack and death, which could have a considerable effect on public health, according to researchers.